-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Cyteir Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2020 to Q3 2023.
- Cyteir Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2023 was -$5.17M, a 56% increase year-over-year.
- Cyteir Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2023 was -$38.3M, a 23.5% increase year-over-year.
- Cyteir Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$48.2M, a 14% decline from 2021.
- Cyteir Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$42.3M, a 102% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)